JPRN-UMIN000004876已完成2 期
Randomized phase II study of pemetrexed plus cisplatin or carboplatin followed by pemetrexed in chemotherapy-naive patients with non-squamous non-small cell lung cancer - Randomized phase II study of pemetrexed plus cisplatin or carboplatin followed by pemetrexed in chemotherapy-naive patients with non-squamous non-small cell lung cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Interstitial pneumonia or pulmonary fibrosis detectable on CT scan. 2)Patients with active co-morbidities including severe conditions. (1)uncontrollable angina pectoris, myocardial infarction within 3 months, severe heart disease. (2)uncontrollable diabetes, hypertension. (3)severe infection (4)paresis of intestine, illeus (5)Patients whose participation in the trial is judged to be inappropriate by the attending doctor. 3)Patients with massive pleural and cardiac effusion and ascites that need to be immediately treated. 4) Brain metastases with neurological symptoms. 5) SVC syndrome. 6) Active double cancer. 7)Pregnancy, breast feeding and suspected pregnancy. 8)History of grave drug allergic reaction. 9) Psychiatric disorder. 10) Patients whose participation in the trial is judged to be inappropriate by the attendeing doctor.
研究者
相似试验
进行中（未招募）
不适用
Randomized Phase II Study Of Pemetrexed And Cisplatin As Either Induction or Adjuvant Chemotherapy In Stage IB-II Non-Small Cell Lung Cancer (NSCLC)Stage IB-II Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 8.0Level: PTClassification code 10029518EUCTR2005-003822-25-GBEuropean Organisation for Research and Treatment of Cancer140
进行中（未招募）
不适用
Randomized Phase II Study Of Pemetrexed And Cisplatin As Either Induction or Adjuvant Chemotherapy In Stage IB-II Non-Small Cell Lung Cancer (NSCLC)EUCTR2005-003822-25-BEEuropean Organisation for Research and Treatment of Cancer140
进行中（未招募）
1 期
An exploratory Phase 2 study of Pemetrexed and Cisplatin as Preoperative chemotherapy in the treatment of Stage IIIAN2 nonsquamous non-Small cell lung cancer - NDEUCTR2009-018148-45-ITEli Lilly and Company Limited
进行中（未招募）
不适用
A Randomized Phase 2 Study of Pemetrexed in Combination with Cisplatin or Carboplatin in the First Line Therapy of Advanced NSCLCadvanced NSCLC of Stage IIIb or IV undergoing first line chemotherapyEUCTR2006-002818-35-DEilly Deutschland GmbH
进行中（未招募）
不适用
A Randomized Phase 2 Study of Pemetrexed in Combination with Cisplatin or Carboplatin as Adjuvant Chemotherapy in Patients with Completely Resected Stage Ib or II Non-Small Cell Lung Cancer - Not availableEUCTR2005-002911-26-DEEli Lilly and Company Limited112